West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier
about
Selenoprotein K knockout mice exhibit deficient calcium flux in immune cells and impaired immune responsesMaturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokinesNeuroinvasion and Inflammation in Viral Central Nervous System InfectionsWest Nile Virus Infection in the Central Nervous SystemNeurological approaches for investigating West Nile virus disease and its treatment in rodentsMechanism of West Nile virus neuroinvasion: a critical appraisalIn Vitro Infection with Dengue Virus Induces Changes in the Structure and Function of the Mouse Brain EndotheliumChanging patterns of West Nile virus transmission: altered vector competence and host susceptibilityIL-10 Signaling Blockade Controls Murine West Nile Virus InfectionProgress on the development of therapeutics against West Nile virusBreakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cellsInduction of endoplasmic reticulum-derived replication-competent membrane structures by West Nile virus non-structural protein 4BImmune Regulation of Antibody Access to Neuronal TissuesEpidemiological and clinical aspects on West Nile virus, a globally emerging pathogen.Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound.Transcellular transport of West Nile virus-like particles across human endothelial cells depends on residues 156 and 159 of envelope proteinTrafficking of immune cells in the central nervous systemOsteopontin facilitates West Nile virus neuroinvasion via neutrophil "Trojan horse" transportIn Vitro and In Vivo Blood-Brain Barrier Models to Study West Nile Virus Pathogenesis.West Nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier modelStructural proteins of West Nile virus are a major determinant of infectious particle production and fitness in astrocytes.Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals.2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivoWest Nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins.Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal deathIL-22 signaling contributes to West Nile encephalitis pathogenesis.Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus.Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytes.Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.Elevation of matrix metalloproteinase-9 level in cerebrospinal fluid of tick-borne encephalitis patients is associated with IgG extravassation and disease severity.Infection of human endothelial cells by Japanese encephalitis virus: increased expression and release of soluble HLA-E.Antiviral macrophage responses in flavivirus encephalitisToll-like receptor-3 is dispensable for the innate microRNA response to West Nile virus (WNV).Neuroinvasion of the highly pathogenic influenza virus H7N1 is caused by disruption of the blood brain barrier in an avian model.Pathogenicity of Highly Pathogenic Avian Influenza Virus H5N1 in Naturally Infected Poultry in Egypt.Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive AntibodiesChronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.
P2860
Q24336556-3483C4E5-F17E-487E-9B1D-1D2CDE210D03Q24570135-1B682558-079C-4989-8B76-D99BBE8186D5Q26745615-125B4A3B-B988-413C-8798-A61D563A6253Q26766121-28042885-E1FE-48CC-8657-91F76FB455C0Q27009096-E2C65848-AFC2-4B3F-B8C3-48EFE0AF0D3CQ27025556-B3CEBC71-D253-49EF-95C2-EFB81532F8B1Q27469037-6CF3C392-8DE4-4582-9386-D6AFB40FF9B4Q27488733-16BB210B-F4D0-4C8F-BEFE-BEF7CDDFD48BQ27489722-74A86453-2481-4798-BAAF-769F46C8BABCQ27489893-24B7AE68-98D4-480A-AF4B-DE87F2930AEEQ28478219-1C917D56-32A7-417C-9BB5-308DE8745B69Q28538841-1E1FDF55-5551-490C-8352-B4C5DC59AE78Q28733365-216FD7FB-E7B0-487D-9FC4-E13241DEC7ABQ30250251-96127F6F-81A3-448A-9E1D-0AD0EE046AD4Q30857727-3E5F94AE-0942-49E3-B3C0-89AAFA21BD40Q31048620-D5F061EE-89CE-48D4-9E31-3CA9ED36CB83Q33596925-77984B8A-9D82-415D-A8DA-4437CB351CECQ33815795-4923E370-2527-4287-B225-266D626E416CQ33875734-CDDBA086-8015-45CB-B5DA-E10544236347Q33885597-E1ADF5E2-55EA-4C10-97E7-4420A507645EQ33921481-2A16AC47-0132-4FD4-89ED-F962D74C6CB3Q34054300-C4CCCE8E-29CC-4084-B991-ED6531C15A05Q34237824-D8571873-E296-4636-9213-76E790F6C337Q34270459-6EB3E3A2-67EB-4AAF-A9E0-0A8C60809B80Q34289114-4963C1EA-9BBE-41AE-9F49-660FFA09A18FQ34321567-F8F20AFB-801A-4E34-8361-D64C502E1BA6Q34406318-B7BBA997-5977-45F4-9A61-10BA6D139DD3Q34406807-0D1F8058-653F-4611-989B-BF31A3E2920AQ34840113-5043A56B-628E-49A4-B66A-F7050BD90125Q35007289-0AD5DFF3-28D9-42A6-994F-435F62FF593BQ35040641-ED96EAE4-8CF1-41E3-BA83-941BB597D068Q35043741-2145A10F-C289-47D2-AF4B-615C26903749Q35085660-EA10BAAE-F8DB-4024-B4C2-38492176B854Q35225674-F645C32E-A044-4DE3-815A-A4E799350399Q35519758-48528E07-AE32-449A-BB54-5C9562B175B1Q35627007-577A39BA-74BE-4E6D-B70E-5F3281FC0CBEQ35641478-6E71B0C9-BBA1-423E-8586-F61EA14870F8Q35739855-61A86803-1218-41EE-B515-F9AEA06F9349Q35758626-0D75807B-9895-45AC-BBE6-EA40A67BC3B0Q35814647-1486BCF0-ECB2-4528-B384-D8555E4FEABE
P2860
West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier
description
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2009/03/15)
@fr
articolo scientifico (pubblicato il 2009/03/15)
@it
artigo científico (publicado na 2009/03/15)
@pt
artículu científicu espublizáu en 2009
@ast
im März 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 15 March 2009)
@en
vedecký článok (publikovaný 2009/03/15)
@sk
videnskabelig artikel (udgivet 2009/03/15)
@da
name
West Nile virus infection modu ...... e in vitro blood-brain barrier
@ast
West Nile virus infection modu ...... e in vitro blood-brain barrier
@en
West Nile virus infection modu ...... e in vitro blood-brain barrier
@nl
type
label
West Nile virus infection modu ...... e in vitro blood-brain barrier
@ast
West Nile virus infection modu ...... e in vitro blood-brain barrier
@en
West Nile virus infection modu ...... e in vitro blood-brain barrier
@nl
prefLabel
West Nile virus infection modu ...... e in vitro blood-brain barrier
@ast
West Nile virus infection modu ...... e in vitro blood-brain barrier
@en
West Nile virus infection modu ...... e in vitro blood-brain barrier
@nl
P2093
P2860
P921
P3181
P1433
P1476
West Nile virus infection modu ...... e in vitro blood-brain barrier
@en
P2093
Austin Nakatsuka
Haiyan Luo
Moti Chapagain
Saguna Verma
Stephanie Lum
Ulziijargal Gurjav
Vivek R Nerurkar
P2860
P304
P3181
P356
10.1016/J.VIROL.2008.11.047
P407
P50
P577
2009-03-15T00:00:00Z